Xue, Yonger http://orcid.org/0000-0002-6022-2487
Zhang, Yuebao http://orcid.org/0009-0000-7883-1937
Zhong, Yichen
Du, Shi
Hou, Xucheng
Li, Wenqing
Li, Haoyuan
Wang, Siyu
Wang, Chang
Yan, Jingyue
Kang, Diana D.
Deng, Binbin
McComb, David W. http://orcid.org/0000-0003-3763-9652
Irvine, Darrell J. http://orcid.org/0000-0002-8637-1405
Weiss, Ron http://orcid.org/0000-0003-0396-2443
Dong, Yizhou http://orcid.org/0000-0001-5786-0659
Article History
Received: 7 May 2023
Accepted: 15 January 2024
First Online: 25 January 2024
Competing interests
: Y.X., Y.Zhang., D.J.I., R.W., and Y.D. are inventors on a patent application (63/433,109) filed by The Ohio State University and Massachusetts Institute of Technology. The patent covers engineered ASCs and their uses in this work. Y.D. is a scientific advisory board member and holds equity in Arbor Biotechnologies and Sirnagen Therapeutics. Y.D. is a co-founder and holds equity in Immunanoengineering Therapeutics. D.J.I. and R.W. are scientific advisory board members and hold equity in Strand Therapeutics. Other authors declare no conflict of interest.